Effect of miR-204&211 and RUNX2 control on the fate of human mesenchymal stromal cells
Regenerative Medicine Research · 2017
DOI: 10.1051/rmr/170004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Regenerative Medicine Research, 2017. Verfasst von Benedetto Sacchetti und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Science, University ROMA TRE, Rome, Italy. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 39 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Science, University ROMA TRE, Rome, Italy.
- Department of Biology and Biotechnology Charles Darwin, "La Sapienza" University, Rome, Italy.
- Exiqon A/S, Skelstedet 16, 2950 Vedbæk, Denmark.
- Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.
- "Regina Elena" National Cancer Institute, Rome, Italy.
- Institute of basic Medical Science, Department for Molecular Medicine, Section for Biochemistry, University of Oslo, Oslo, Norway.
Zitieren
APA
Sacchetti, B., Fatica, A., Sorci, M., Sorrentino, A., Signore, M., Cerio, A., Felicetti, F., Feo, A., Pelosi, E., Caré, A., Pescarmona, E., Gordeladze, J. O., & Valtieri, M. (2017). Effect of miR-204&211 and RUNX2 control on the fate of human mesenchymal stromal cells. Regenerative Medicine Research. https://doi.org/10.1051/rmr/170004
Vancouver
Sacchetti B, Fatica A, Sorci M, Sorrentino A, Signore M, Cerio A, et al. Effect of miR-204&211 and RUNX2 control on the fate of human mesenchymal stromal cells. Regenerative Medicine Research. 2017. doi:10.1051/rmr/170004
BibTeX
@article{Sacchetti2017,
author = {Sacchetti, Benedetto and Fatica, Alessandro and Sorci, Melissa and Sorrentino, Antonio and Signore, Michele and Cerio, Annamaria and Felicetti, Federica and Feo, Alessandra De and Pelosi, Elvira and Caré, Alessandra and Pescarmona, Edoardo and Gordeladze, Jan Oxholm and Valtieri, Mauro},
title = {Effect of miR-204&211 and RUNX2 control on the fate of human mesenchymal stromal cells},
journal = {Regenerative Medicine Research},
year = {2017},
doi = {10.1051/rmr/170004}
}
EUVIMED